References
- Ekamol Tantisattamo MZ, Molnar BT, Ho UG, et al. Approach and management of hypertension after kidney transplantation. Front Med. 2020;7:229. doi:10.3389/fmed.2020.00229
- Ekamol Tantisattamo RM, Hanna UG, Reddy HI, Dafoe DC, Danovitch GM, Kalantar-Zadeh K. Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy. Curr Opin Nephrol Hypertens. 2020;29(1):80–91. doi:10.1097/MNH.0000000000000572
- Uwe Heemann DA, Hesselink AL, Oberbauer R, et al. Allograft function as endpoint for clinical trials in kidney transplantation. Transpl Int. 2022;35:10139. doi:10.3389/ti.2022.10139
- Lebraud E, Eloudzeri M, Rabant M, Lamarthée B, Anglicheau D. Microvascular inflammation of the renal allograft: a reappraisal of the underlying mechanisms. Front Immunol. 2022;13:864730. doi:10.3389/fimmu.2022.864730
- Quaglia M, Merlotti G, Guglielmetti G, Castellano G, Cantaluppi V. Recent advances on biomarkers of early and late kidney graft dysfunction. Int J Mol Sci. 2020;21(15):5404. doi:10.3390/ijms21155404
- Ramalhete LM, Araújo R, Aníbal Ferreira CR, Calado C. Proteomics for biomarker discovery for diagnosis and prognosis of kidney transplantation rejection. Proteomes. 2022;10(3):24. doi:10.3390/proteomes10030024
- Varnell CD Jr, Rich KL, Zhang B, et al. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication. Pediatr Nephrol. 2021;36(8):2453–2461. doi:10.1007/s00467-021-04946-8
- Fekih RE, Hurley J, Tadigotla V, et al. Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection. J Am Soc Nephrol. 2021;32(4):994–1004. doi:10.1681/ASN.2020060850
- Cooper JE. Evaluation and treatment of acute rejection in kidney allografts. Clin J Am Soc Nephrol. 2020;15(3):430–438. doi:10.2215/CJN.11991019
- Hautz T, Messner F, Weissenbacher A, et al. Long‐term outcome after hand and forearm transplantation – a retrospective study. Transpl Int. 2020;33(12):1762–1778. doi:10.1111/tri.13752
- Jeong HJ. Diagnosis of renal transplant rejection: Banff classification and beyond. Kidney Res Clin Pract. 2020;39(1):17–31. doi:10.23876/j.krcp.20.003
- Zhang H, Wang Z, Zhang J, et al. Combined immunotherapy with belatacept and BTLA overexpression attenuates acute rejection following kidney transplantation. Front Immunol. 2021;12:618737. doi:10.3389/fimmu.2021.618737
- Diedrich CR, Gideon HP, Rutledge T, Baranowski TM, Pauline Maiello AJ, Lin MPL. CD4CD8 double positive T cell responses during Mycobacterium tuberculosis infection in cynomolgus macaques. J Med Primatol. 2019;48(2):82–89. doi:10.1111/jmp.12399
- Zhang H, Wang Y, Ying M, et al. Increased CD4+CD8+ double positive T cells during hantaan virus infection. Viruses. 2022;14(10):2243. doi:10.3390/v14102243
- Chen Y, Zhang B, Liu T, Chen X, Wang Y, Zhang H. T cells with activated STAT4 drive the high-risk rejection state to renal allograft failure after kidney transplantation. Front Immunol. 2022;13:895762. doi:10.3389/fimmu.2022.895762
- Toshihito Hirai AT, Mayer TW, Po-Yu Lin N, et al. Imaging alloreactive T cells provides early warning of organ transplant rejection. JCI Insight. 2021;6(13):e145360. doi:10.1172/jci.insight.145360
- Borges TJ, Phammela Abarzua RB, Gassen BK, et al. T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation. Cell Rep Med. 2022;3(3):100559. doi:10.1016/j.xcrm.2022.100559
- Wang J, Jelcic I, Mühlenbruch L, et al. HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis. Cell. 2020;183(5):1264–1281. doi:10.1016/j.cell.2020.09.054
- Wesley Huisman DA, Leboux T, van der Maarel LE, et al. Magnitude of Off-Target Allo-HLA reactivity by third-party donor-derived virus-specific T cells is dictated by HLA-restriction. Front Immunol. 2021;12:630440. doi:10.3389/fimmu.2021.630440
- McKinney DM, Southwood S, Hinz D, et al. A strategy to determine HLA class II restriction broadly covering the DR, DP and DQ allelic variants most commonly expressed in the general population. Immunogenetics. 2013;65(5):357–370. doi:10.1007/s00251-013-0684-y